Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Agnusdei

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Menopause (New York, N.Y.)|August 5, 1998
Effect of ipriflavone--a synthetic derivative of natural isoflavones--on bone mass loss in the early years after menopauseC Gennari, D Agnusdei, G Crepaldi, et al.
Proceedings of the Royal Society of Medicine|October 5, 2010
Action of cinnarizine on the hyperviscosity of blood in patients with peripheral obliterative arterial diseaseT Di Perri, S Forconi, M Guerrini, et al.
Calcified Tissue International|August 1, 1997
A double blind, placebo-controlled trial of ipriflavone for prevention of postmenopausal spinal bone lossD Agnusdei, G Crepaldi, G Isaia, et al.
The British Journal of Radiology|August 1, 1995
Ultrasonographic assessment of bone in normal Italian males and femalesC Cepollaro, D Agnusdei, S Gonnelli, et al.
Circulation Research|March 1, 1987
Cardiovascular effects of calcitonin gene-related peptides I and II in manA Franco-Cereceda, C Gennari, R Nami, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 21, 2008
Osteoporosis treatment and fracture incidence: the ICARO longitudinal studyS Adami, G Isaia, G Luisetto, et al.
Bone|February 22, 2002
The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitroA Taranta, M Brama, A Teti, et al.
Bone and Mineral|October 1, 1992
Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosisD Agnusdei, S Adami, R Cervetti, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1996
The development of a European questionnaire for quality of life in patients with vertebral osteoporosisP Lips, D Agnusdei, F Caulin, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1997
Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for OsteoporosisP Lips, C Cooper, D Agnusdei, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Menopause (New York, N.Y.)|August 5, 1998
Effect of ipriflavone--a synthetic derivative of natural isoflavones--on bone mass loss in the early years after menopauseC Gennari, D Agnusdei, G Crepaldi, et al.
Proceedings of the Royal Society of Medicine|October 5, 2010
Action of cinnarizine on the hyperviscosity of blood in patients with peripheral obliterative arterial diseaseT Di Perri, S Forconi, M Guerrini, et al.
Calcified Tissue International|August 1, 1997
A double blind, placebo-controlled trial of ipriflavone for prevention of postmenopausal spinal bone lossD Agnusdei, G Crepaldi, G Isaia, et al.
The British Journal of Radiology|August 1, 1995
Ultrasonographic assessment of bone in normal Italian males and femalesC Cepollaro, D Agnusdei, S Gonnelli, et al.
Circulation Research|March 1, 1987
Cardiovascular effects of calcitonin gene-related peptides I and II in manA Franco-Cereceda, C Gennari, R Nami, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 21, 2008
Osteoporosis treatment and fracture incidence: the ICARO longitudinal studyS Adami, G Isaia, G Luisetto, et al.
Bone|February 22, 2002
The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitroA Taranta, M Brama, A Teti, et al.
Bone and Mineral|October 1, 1992
Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosisD Agnusdei, S Adami, R Cervetti, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1996
The development of a European questionnaire for quality of life in patients with vertebral osteoporosisP Lips, D Agnusdei, F Caulin, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1997
Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for OsteoporosisP Lips, C Cooper, D Agnusdei, et al.
Pageof 7